Interactive Decision Support Tool


Share

Program Content

Activities

  • IDST for BTKi AEs
    Interactive Tool to Guide Management of Adverse Events With BTK Inhibitor Therapy in Hematologic Malignancies
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 07, 2025

    Expires: January 06, 2026

Faculty

cover img faculity

Toby A Eyre, MBChB, MD

Hematology Consultant
Honorary Senior Lecturer at the University of Oxford
Oxford University Hospitals NHS Trust
Oxford, United Kingdom

cover img faculity

Arnon Kater, MD, PhD

Professor of Hematology
Deputy Head of Department
Chairman, HOVON CLL Working Group and President, HOVON Executive Board
Department of Hematology
Lymphoma and Myeloma Research Amsterdam
Amsterdam, Netherlands

cover img faculity

Vincent Ribrag, MD

Hematology Department
Chief Molecular Therapeutics in Hematological Early Drug Development
Gustave Roussy
Villejuif, France

cover img faculity

Stephan Stilgenbauer, MD

Medical Director, Comprehensive Cancer Center Ulm
Head, Early Clinical Trials Unit
Head, Division of CLL
Department of Internal Medicine III
Comprehensive Cancer Center Ulm
University Medical Center Ulm
Ulm, Germany

cover img faculity

Alessandra Tedeschi, MD

Medical Doctor
Department of Hematology
Niguarda Cancer Center Milano
Milano, Italy

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca